Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Population in Improving Eearly Diagnosis Efficancy in Chinese

Recruiting
  • Carcinoma, Hepatocellular
  • +4 more
  • Liver cancer surveillance every 3 months
  • +2 more
  • Shanghai, Shanghai, China
    Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular Trial in China (Amivantamab)

Recruiting
  • Carcinoma, Hepatocellular
  • Beijing, China
  • +15 more
Jan 27, 2023

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022

Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Gastric/Gastroesophageal Junction Cancer
  • Hefei, Anhui, China
  • +17 more
Jul 28, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Carcinoma, Hepatocellular Trial in Shanghai (Pembrolizumab+Lenvatinib)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 24, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Sorafenib (BAY43-9006)
  • Louisville, Kentucky
  • +78 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Regorafenib (Stivarga, BAY73-4506)
  • Placebo
  • Los Angeles, California
  • +146 more
Aug 11, 2020

Prospective Surveillance for Very Early Hepatocellular Carcinoma

Recruiting
  • Carcinoma, Hepatocellular
    • Chongqing, Chongqing, China
    • +12 more
    May 20, 2020

    Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (JNJ-42756493 (erdafitinib))

    Completed
    • Carcinoma, Hepatocellular
    • JNJ-42756493 (erdafitinib)
    • Changchun, China
    • +9 more
    Feb 17, 2020

    Carcinoma, Hepatocellular Trial in Shanghai (RT, TACE)

    Unknown status
    • Carcinoma, Hepatocellular
    • RT
    • TACE
    • Shanghai, Shanghai, China
      Zhongshan Hosptial
    May 4, 2019

    Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Nexavar (Sorafenib, BAY43-9006)
    • Placebo
    • Birmingham, Alabama
    • +198 more
    Jul 11, 2018

    Carcinoma, Hepatocellular Trial in Shanghai (Apatinib)

    Unknown status
    • Carcinoma, Hepatocellular
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Aug 24, 2017

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • Placebo
    • La Jolla, California
    • +106 more
    Jul 18, 2017

    Carcinoma, Hepatocellular Trial in Shanghai (Enhanced Recovery After Surgery)

    Unknown status
    • Carcinoma, Hepatocellular
    • Enhanced Recovery After Surgery
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Jun 24, 2017

    Carcinoma, Hepatocellular, Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Shanghai (CAR-T cell)

    Unknown status
    • Carcinoma, Hepatocellular
    • +2 more
    • CAR-T cell
    • Shanghai, Shanghai, China
      Shanghai Tumor Hospital
    Nov 7, 2016

    Carcinoma, Hepatocellular Trial in Shanghai (procedure, drug, other)

    Unknown status
    • Carcinoma, Hepatocellular
    • Thermal Ablation
    • +3 more
    • Shanghai, Shanghai, China
      Department of Interventional Radiology, Zhongshan Hospital, Fuda
    Oct 17, 2016

    Carcinoma, Hepatocellular Trial in Shanghai (TAI-GPC3-CART cells)

    Unknown status
    • Carcinoma, Hepatocellular
    • TAI-GPC3-CART cells
    • Shanghai, Shanghai, China
      Renji Hospital, Shanghai Jiao Tong University School of Medicine
    Mar 16, 2016

    Carcinoma, Hepatocellular, Neoplastic Cells, Circulating Trial in China (TACE, Epirubicin, lipiodol)

    Unknown status
    • Carcinoma, Hepatocellular
    • Neoplastic Cells, Circulating
    • TACE
    • +2 more
    • Guangzhou, Guangdong, China
    • +5 more
    Dec 20, 2015

    Carcinoma, Hepatocellular Trial in Shanghai (Huachansu, TACE)

    Unknown status
    • Carcinoma, Hepatocellular
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 16, 2015

    Carcinoma, Hepatocellular Trial in Worldwide (Brivanib, Placebo)

    Terminated
    • Carcinoma, Hepatocellular
    • Hefei, Anhui, China
    • +31 more
    Sep 23, 2015